Advertisement

Topics

Sanofi Sees Immunology Momentum Heading Toward Cures

15:08 EDT 21 Jun 2017 | SCRIP

Sanofi is looking to develop new mechanisms of action and multi-targeted approaches in immunology and inflammation, with a vision of...

      

Related Stories

 

Original Article: Sanofi Sees Immunology Momentum Heading Toward Cures

NEXT ARTICLE

More From BioPortfolio on "Sanofi Sees Immunology Momentum Heading Toward Cures"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...